Corcept Therapeutics Incorporated has grown revenue 23% a year over three years and 18% a year over five, with earnings per share compounding at −25%. Revenue growth, 3-year annual rate: +23% (Biotechnology median +21%). Revenue growth, 5-year rate: +18%, growth has picked up over the last three years. Earnings per share, 3-year rate: −25%, earnings lagged revenue: the growth is costing something. Years of annual history on file: 26, FY2000 to FY2025, as filed.

CORTCorcept Therapeutics Incorporated

HealthcareUSD

$119.82

$32.1552 weeks$123.53

Is it growing?

Is CORT growing?

Corcept Therapeutics Incorporated has grown revenue 23% a year over three years and 18% a year over five, with earnings per share compounding at −25%.

+23%

Revenue growth, 3-year annual rate · Biotechnology median +21% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +18%
Revenue growth, 5-year rate · +23% over three · growth has picked up over the last three years
Earnings per share, 3-year rate: −25%
Earnings per share, 3-year rate · revenue +23% · earnings lagged revenue: the growth is costing something
Years of annual history on file: 26
Years of annual history on file · FY2000 to FY2025, as filed